Subscribe to RSS
Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery
Received: 18 August 1995
Accepted after revision06 November 1995
31 August 2018 (online)
Perioperative anticoagulant prophylaxis for postoperative venous thromboembolism (VTE) in neurosurgical patients has not gained wide acceptance due to the fear of intracranial bleeding. Physical methods give a worthwhile reduction of postoperative VTE but there still remains a substantial residual incidence. In other clinical indications, low molecular weight heparins have proven to be effective for prophylaxis of VTE when administered postoperatively, with the advantage of no bleeding enhancement during surgery.
Therefore, we performed a multicentre, randomized, double-blind trial in neurosurgical patients to investigate the efficacy and safety of adding a low molecular weight heparin (LMWH), nadroparin, initiated postoperatively, to graduated compression stockings in the prevention of VTE. Deep-vein thrombosis was detected by mandatory venography. Bleeding was determined according to pre-defined objective criteria for major and minor episodes.
An adequate bilateral venogram was obtained in 166 of 241 LMWH patients (68.9%) and 179 of 244 control patients (73.4%). A total of 31 of 166 LMWH patients (18.7%) and 47 of 179 control patients (26.3%) had VTE up to Day 10 postoperatively (p = 0.047). The relative risk reduction (RRR) was 28.9%. The rates for proximal deep-vein thrombosis/pulmonary embolism were 6.9% and 11.5% for the two groups, respectively (RRR: 40.2%; p = 0.065).
Secondary analyses involved all VTE up to day 56 post-surgery which was detected in 33 patients of 241 in the LMWH group (13.7%) and 51 of 244 control patients (20.9%; RRR 34.5%; p = 0.018). The corresponding percentages for proximal deep-vein thrombosis/pulmonary embolism were 5.8% and 10.2% for the two groups, respectively, giving a RRR of 43.3%; p = 0.036. Major bleeding complications, during the treatment period, occurred in six low molecular weight heparin treated patients (2.5%) and in two control patients (0.8%); p = 0.087.
A higher mortality was observed in the low molecular weight heparin group over the 56-day follow-up period (22 versus 10; p = 0.026). However, none of these deaths was judged by a blinded adjudication committee to be related to the study drug.
In conclusion, this study demonstrates that the low molecular weight heparin, nadroparin, added to graduated compression stockings results in a clinically significant decrease in VTE without inducing any significant increase of major bleeding.
- 1 Swann KW, Black PM, Maker MF. Management of symptomatic deep venous thrombosis and pulmonary embolism in a neurosurgical service. J Neurosurgery 1986; 64: 563-567
- 2 Skillman JJ, Collins REC, Coe NP, Goldstein BS, Shapiro RS, Zervas NT, Bettmann MA, Salzman EW. Prevention of deep vein thrombosis in neurosurgical patients. A controlled randomized trial of external compression boots. J Surg 1978 83. 354-358
- 3 Turpie AGG, Gallus AS, Beattie WS, Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 1977; 5: 435-438
- 4 Turpie AGG, Delmore T, Hirsh J, Hull R, Genton E, Hiscoe C, Gent M. Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res 1979; 15: 611-616
- 5 Turpie AGG, Gent M, Doyle DJ, Saerens E, de Boer AC, Talbot C, McNa-mee J, Hirsh J. An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients. Thromb Res 1985; 39: 173-181
- 6 Sigel B, Ipsen J, Felix WR. The epidemiology of lower extremity deep venous thrombosis in surgical patients. Ann Surg 1974; 179: 278-290
- 7 Watson N. Anticoagulant therapy in the treatment of venous thrombosis and pulmonary embolism in acute spinal injury. Paraplegia 1974; 12: 197
- 8 Turpie AGG. Low molecular weight heparins and heparinoids for prevention of venous thromboembolism in stroke and neurosurgical patients. In: Low molecular weight heparins in prophylaxis and therapy of thromboembolic diseases Bounameaux H. ed New York: Marcel Dekker Inc; 1994: 213-223
- 9 Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: A review. Neurosurgery 1994; 34: 280-296
- 10 Bostrom S, Holmgren E, Jonsson O, Lindberg S, Lindstrom B, Winso I, Zachrisson B. Postoperative thromboembolism in neurosurgery: A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin. Acta Neurochir 1986; 80: 83-89
- 11 Bucci MN, Papadopoulos SM, Chen JC, Campbell JA, Hoff JT. Mechanical prophylaxis in patients undergoing craniotomy: a randomized trial. Surg Neurol 1989; 32: 285-288
- 12 Frim DM, Barker IIFG, Poletti CE, Hamilton AJ. Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 1992; 30: 830-832
- 13 Turpie AGG, Hirsh J, Gent M, Julian D, Johnson J. Prevention of deep vein thrombosis in potential neurosurgical patients: A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Int Med 1989; 149: 679-681
- 14 Cerrato D, Ariano C, Fiacchin F. Deep vein thrombosis and low dose heparin prophylaxis in neurosurgical patients. J Neurosurg 1978; 49: 378-381
- 15 Barnett HG, Clifford JR, Llwellyn C. Safety of mini-dose heparin administration for neurosurgical patients. J Neurosurg 1977; 47: 27-30
- 16 Powers SK, Edwards MSB. Prophylaxis of thromboembolism in the neurosurgical patient: a review. Neurosurgery 1982; 10: 509-513
- 17 Andersson LO, Barrowcliffe TW, Holmer E, Jonson EA, Sims GEC. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 975-983
- 18 Messmore Jr HL, Griffin B, Fareed J, Coyne E, Seghatchian J. In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets. Ann NY Acad Sci 1989; 556: 217-233
- 19 ten Cate H, Henny ChP, ten Cate JW, Biiller HR, Mooy MC, Surachno S, Wilmink JM. Use of a low molecular weight heparinoid in volunteers and hemodialysis patients. Thromb Res 1985; 38: 211-212
- 20 Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP, Briët E. The efficacy and safety of low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-156
- 21 Leizorovicz A, Haugh MC, Chapuis FR, Samama M, Boissel JP. Low-molecular weight heparin in the prevention of perioperative thrombosis. Brit Med J 1992; 305: 913-920
- 22 Jørgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704
- 23 Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Van-denbroek MD. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low-molecu-lar-weight heparin. BMJ 1991; 303: 543-548
- 24 Encke A, Breddin K. Comparison of low-molecular-weight heparin and unfractionated heparin for the prevention of deep-vein thrombosis in patients undergoing abdominal surgery. Br J Surg 1988; 75: 1058-1063
- 25 Barradell LB, Buckley MM. Nadroparin calcium: a review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Drugs 1992; 44: 858-868
- 26 Turpie AGG, Levine MN, Hirsh J, Carter CC, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. A randomized trial of a low molecular weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-929
- 27 Levine MN, Hirsh J, Gent M, Turpie AGG, Leclerc J, Powers PJ, Jay RM, Neemeh J. Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991; 114: 545-551
- 28 Leclerc JR, Geerts WH, Desjardins L, Jobin F, Laroche F, Delorme F, Haviemick S, Atkinson S, Bourgouin J. Prevention of deep vein thrombosis after major surgery: a randomized, double-blind trial comparing a low molecular weight heparin fragment (Enoxaparin) to placebo. Thromb Haemost 1992; 67: 417-423
- 29 Hull R, Raskob G, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D, Elliott G, Panju A, Brant R. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-1376
- 30 Lensing AWA, Prandoni P, Brandjes DPM, Huisman PM, Vigo M, Tomas-sella G, Krekt J, ten Cate JW, Huisman MV, Büller HR. Detection of deep vein thrombosis by real-time B-mode ultra-sonography. N Engl J Med 1989; 320: 342-345
- 31 Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis of the leg. Arch Surg 1972; 104: 134-144
- 32 Lensing AWA, Hirsh J, Büller HR. Diagnosis of venous thrombosis. In: Hemostasis and thrombosis: basic principles and clinical practice Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. 3rd ed Philadelphia: JB Lip-pincottCo; 1994: 1297-1322
- 33 Kakkar VV, Murray WJG. Efficacy and safety of low molecular weight heparin (CY216) in preventing postoperative venous thromboembolism. Br J Surg 1985; 72: 786-791
- 34 Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley 1981: 19-27
- 35 Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959; 22: 719-748
- 36 Büller HR, Lensing AWA, Hirsh J, ten Cate JW. Deep venous thrombosis: New non-invasive diagnostic tests. Thromb Haemost 1991; 66: 133-137
- 37 Prandoni P, Lensing AWA, Büller HR, Carter M, Cogo A, Vigo M, Casara D, Rual A, ten Cate JW. Comparison of subcutaneous low molecular weight heparin with intravenous unfractionated heparin in proximal deep vein thrombosis. Lancet 1992; 339: 441-445
- 38 Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994; 309: 299-304